Knockout mouse models and mammary tumorigenesis

Seminars in Cancer Biology

Volumn 11, Issue 5, 2001, Pages 387-394

  Deng, Chu Xia ^a   Brodie, Steven G ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Breast cancer; Cell cycle checkpoint; Conditional knockout; DNA damage repair; Genetic stability

Indexed keywords

PROTEIN P53;

ANIMAL MODEL; BREAST CARCINOGENESIS; DNA DAMAGE; DNA REPAIR; GENE ACTIVATION; GENE DELETION; GENE OVEREXPRESSION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; REVIEW; TRANSGENIC MOUSE; TUMOR GROWTH; TUMOR PROMOTION; TUMOR SUPPRESSOR GENE;

EID: 0034748550     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.2001.0394     Document Type: Article

References (52)

1. Breast cancer susceptibility genes. BRCA1 and BRCA2
2. Epidemiology, prevention, and early detection of breast cancer
3. Cancer risk and the ATM gene: A continuing debate
4. PTEN, a unique tumor suppressor gene
5. Inherited breast cancer: An emerging picture
6. Reproductive factors in hereditary breast cancer
7. The mammary pathology of genetically engineered mice: The consensus report and recommendations from the Annapolis meeting
8. Twenty years of p53 research: Structural and functional aspects of the p53 protein
9. Identification and characterization of the familial adenomatous polyposis coli gene
10. Somatic mutations of the APC gene in primary breast cancers
11. Suppression of polypogenesis in a new mouse strain with a truncated Apc(Delta474) by a novel COX-2 inhibitor, JTE-522
12. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene
13. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene
14. ROSA26 mice carry a modifier of Min-induced mammary and intestinal tumor development
15. Eighth international workshop on Ataxia-Telangiectasia (ATW8)
16. The role of ataxia-telangiectasia heterozygotes in familial breast cancer
17. Atm-deficient mice: A paradigm of ataxia telangiectasia
18. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma
19. Pleiotropic defects in ataxia-telangiectasia protein-deficient mice
20. Critical role for Atm in suppressing V(D)J recombination-driven thymic lymphoma
21. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
22. The BRCA1 and BRCA2 breast cancer genes
23. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells
24. Roles of BRCA1 and its interacting proteins
25. Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities
26. A targeted disruption of the murine Brca1 gene causes g-radiation hypersensitivity and genetic instability
27. The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse
28. Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development
29. Targeted mutations of breast cancer susceptibility, gene homologs in mice: Lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos
30. Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation
31. BRCA1 required for transcription-coupled repair of oxidative DNA damage
32. Brca1 controls homology-directed DNA repair
33. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation
34. Temporal, spatial, and cell type-specific control of Cre-mediated DNA recombination in transgenic mice
35. Embryonic lethality and radiation hypersensitivity, mediated by Rad51 in mice lacking Brca2
36. Involvement of Brca2 in DNA repair
37. Partial rescue of Brca1 (5-6) early embryonic lethality by p53 or p21 null mutation
38. Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation
39. Mitotic checkpoint inactivation fosters transformation in cells lacking the breast cancer susceptibility gene. Brca2
40. High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice
41. Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms
42. Is TP53 dysfunction required for BRCA1-associated carcinogenesis?
43. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
44. Infrequent p53 mutations in 7,12-dimethylbenz[a]anthracene-induced mammary tumors in BALB/c and p53 hemizygous mice
45. Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice. A model for Li-Fraumeni syndrome
46. A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development
47. Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability
48. Inactivation of p53 tumor suppressor gene acts synergistically with c-neu oncogene in salivary gland tumorigenesis
49. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice
50. Neu/ERBB2 cooperates with p53-172H during mammary tumorigenesis in transgenic mice
51. Increased tumor proliferation and genomic instability without decreased apoptosis in MMTV-ras mice deficient in p53
52. Cooperative interaction between mutant p53 and des(1-3)IGF-I accelerates mammary tumorigenesis